Ampyra & Therapy cessation

9.7%

of users reported Therapy cessation

43.1%

also reported Hospitalization

72.1%

are women

Hospitalization

43.1%

Severe reaction

37.3%

Disability

17.9%

Death

1.3%

Life-threatening condition

0.3%

Ampyra: general information

20 - 29 years

1.0%

30 - 39 years

7.0%

40 - 49 years

17.9%

50 - 59 years

35.3%

60 - 69 years

29.5%

70 - 79 years

8.4%

80 - 89 years

0.7%